Home
>
National Drug Code (NDC)
>
Plavix
Plavix - 63653-1332-2 - (clopidogrel bisulfate)
Drug Information of Plavix
| Product NDC: | 63653-1332 |
| Proprietary Name: | Plavix |
| Non Proprietary Name: | clopidogrel bisulfate |
| Active Ingredient(s): | 300 mg/1 & nbsp; clopidogrel bisulfate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Plavix
| Product NDC: | 63653-1332 |
| Labeler Name: | Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020839 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19000101 |
Package Information of Plavix
| Package NDC: | 63653-1332-2 |
| Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (63653-1332-2) |
NDC Information of Plavix
| NDC Code | 63653-1332-2 |
| Proprietary Name | Plavix |
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (63653-1332-2) |
| Product NDC | 63653-1332 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | clopidogrel bisulfate |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19000101 |
| Marketing Category Name | NDA |
| Labeler Name | Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership |
| Substance Name | CLOPIDOGREL BISULFATE |
| Strength Number | 300 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA] |
